NGNE
Income statement / Annual
Last year (2023), Neurogene Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Neurogene Inc.'s net income was -$36.32 M.
See Neurogene Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$25.00 M
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3.26 M |
$3.20 M |
$2.28 M |
$1.82 M |
$340,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$3.26 M |
-$3.20 M |
-$2.28 M |
-$1.82 M |
-$340,000.00 |
$25.00 M |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
| Research and Development
Expenses |
$44.39 M
|
$47.51 M
|
$42.26 M
|
$24.34 M
|
$6.32 M
|
$32.79 M
|
$36.27 M
|
$28.38 M
|
| General & Administrative
Expenses |
$11.19 M
|
$9.01 M
|
$8.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$11.19 M
|
$9.01 M
|
$8.27 M
|
$15.39 M
|
$17.79 M
|
$15.74 M
|
$14.85 M
|
$9.26 M
|
| Other Expenses |
$0.00 |
-$7,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$55.58 M |
$56.52 M |
$50.53 M |
$39.73 M |
$24.10 M |
$48.52 M |
$51.12 M |
$37.65 M |
| Cost And Expenses |
$55.58 M |
$56.52 M |
$50.53 M |
$41.55 M |
$24.44 M |
$48.52 M |
$51.12 M |
$37.65 M |
| Interest Income |
$2.95 M |
$1.34 M |
$17,000.00 |
$490,000.00 |
$1.54 M |
$1.56 M |
$998,000.00 |
$619,000.00 |
| Interest Expense |
$12,000.00 |
$2,000.00 |
$0.00 |
$0.00 |
$1,000.00 |
$4,000.00 |
$4,000.00 |
$1,000.00 |
| Depreciation &
Amortization |
$3.30 M
|
$3.20 M
|
$2.28 M
|
$1.82 M
|
$340,000.00
|
$0.00
|
$1.00
|
$1.00
|
| EBITDA |
-$52.29 M
|
-$51.99 M
|
-$49.59 M
|
-$31.46 M
|
-$69.10 M
|
-$31.58 M
|
-$50.18 M
|
-$37.00 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
-0.94 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
-0.94
|
0
|
0
|
| Total Other
Income/Expenses Net |
$19.27 M
|
$1.33 M
|
$17,000.00
|
$8.28 M
|
-$45.00 M
|
-$8.06 M
|
$936,000.00
|
$643,000.00
|
| Income Before Tax |
-$36.32 M |
-$55.19 M |
-$50.52 M |
-$33.28 M |
-$69.44 M |
-$31.59 M |
-$50.18 M |
-$37.00 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
-1.26
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$5,000.00 |
$17,000.00 |
-$1.00 |
$168,140.00 |
$0.00 |
-$1.00 |
-$1.00 |
| Net Income |
-$36.32 M |
-$55.19 M |
-$50.52 M |
-$33.28 M |
-$69.44 M |
-$31.59 M |
-$50.18 M |
-$37.00 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
-1.26 |
0 |
0 |
| EPS |
-2.83 |
-4.3 |
-0.92 |
-0.64 |
-2.57 |
-1.34 |
-2.14 |
-1.96 |
| EPS Diluted |
-2.83 |
-4.3 |
-0.92 |
-0.64 |
-2.57 |
-1.34 |
-2.14 |
-1.96 |
| Weighted Average Shares
Out |
$12.82 M
|
$12.82 M
|
$55.04 M
|
$51.83 M
|
$27.03 M
|
$23.52 M
|
$23.45 M
|
$18.89 M
|
| Weighted Average Shares
Out Diluted |
$12.82 M
|
$12.82 M
|
$55.04 M
|
$51.83 M
|
$27.03 M
|
$23.52 M
|
$23.45 M
|
$18.89 M
|
| Link |
|
|
|
|
|
|
|
|
